The Complementary Nature of Patient-Reported Outcomes (PROs) and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591) Atherton, Pamela J. , Watkins-Bruner, Deborah W. , Gotay, Carolyn ... - - J Pain Symptom Manage - 2015 Manuscript - Primary - Primary - Health Outcome - N0591
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials Atkinson, Thomas M. , Dueck, Amylou C. , Satele, Daniel V. ... - - JAMA Oncol - 2020 Manuscript - Secondary - Meta-Analysis - Health Outcome - N0591
Comparison Between Clinician- and Patient-Reporting of Baseline (BL) and Post-BL Symptomatic Toxicities in Cancer Cooperative Group Clinical Trials (NCCTG N0591 [Alliance]) Atkinson, Thomas M. , Satele, Daniel V. , Sloan, Jeff A. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - Health Outcome - N0591
A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance) Barton, Debra L , Atherton, Pamela J , Satele, Daniel V , Qin, Rui ... - - Support Care Cancer - 2020 Manuscript - Primary - Primary - Symptom Inter - NCCTG-N07C4
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - Symptom Inter - N05C5